Logo-apb
Adv Pharm Bull. 2020;10(2): 166-183. doi: 10.34172/apb.2020.022
PMID: 32373486        PMCID: PMC7191229

Review Article

Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics

Dipak Dilip Gadade 1,2 * ORCID, Sanjay Sudhakar Pekamwar 2 ORCID

Cited by CrossRef: 65


1- Otieno E, Huang Y, Li N, Li T, Wang M, Qiu X, Xiao X. Utilization of superparamagnetic iron oxide nanoparticles (SPIONs) as a vector for drug delivery. Appl Nanosci. 2023;13(9):6191 [Crossref]
2- Alavi M, Varma R. Antibacterial and wound healing activities of silver nanoparticles embedded in cellulose compared to other polysaccharides and protein polymers. Cellulose. 2021;28(13):8295 [Crossref]
3- Soni S, D'Elia A, Alsasa A, Cho S, Tylek T, O'Brien E, Whitaker R, Spiller K, Rodell C. Sustained release of drug-loaded nanoparticles from injectable hydrogels enables long-term control of macrophage phenotype. Biomater Sci. 2022;10(24):6951 [Crossref]
4- Veetil V, Rajeeve A, G.P S, Manish Kumar K, Bhagiyalakshmi M, Vinoba M, Yamuna R. β-Cyclodextrin capped ZnS nanoparticles for CER-assisted colorimetric and spectrophotometric detection of Pb2⁺, Cu2⁺, and Hg2⁺ in an aqueous solution. Heliyon. 2023;9(11):e21850 [Crossref]
5- Wong K, Lu A, Chen X, Yang Z. Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment. Molecules. 2020;25(16):3620 [Crossref]
6- Huanbutta K, Suwanpitak K, Weeranoppanant N, Sriamornsak P, Garg K, Sharma S, Singh I, Sangnim T. Continuous flow synthesis: A promising platform for the future of nanoparticle-based drug delivery. Journal of Drug Delivery Science and Technology. 2024;91:105265 [Crossref]
7- Ghitman J, Voicu S. Controlled drug delivery mediated by cyclodextrin-based supramolecular self-assembled carriers: From design to clinical performances. Carbohydrate Polymer Technologies and Applications. 2023;5:100266 [Crossref]
8- Bognanni N, Viale M, Distefano A, Tosto R, Bertola N, Loiacono F, Ponassi M, Spinelli D, Pappalardo G, Vecchio G. Cyclodextrin Polymers as Delivery Systems for Targeted Anti-Cancer Chemotherapy. Molecules. 2021;26(19):6046 [Crossref]
9- Bognanni N, Viale M, La Piana L, Strano S, Gangemi R, Lombardo C, Cambria M, Vecchio G. Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems. Pharmaceutics. 2023;15(2):374 [Crossref]
10- Parvez S, Yadagiri G, Arora K, Javaid A, Kushwaha A, Singh O, Sundar S, Mudavath S. Coalition of Biological Agent (Melatonin) With Chemotherapeutic Agent (Amphotericin B) for Combating Visceral Leishmaniasis via Oral Administration of Modified Solid Lipid Nanoparticles. ACS Biomater Sci Eng. 2023;9(6):2902 [Crossref]
11- Yilmaz A, Sahiner N. Super porous α‐, β‐, γ‐cyclodextrin cryogels with high active agent loading and controllable release profiles. J of Applied Polymer Sci. 2024;141(3) [Crossref]
12- Yakkala P, Penumallu N, Shafi S, Kamal A. Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents. Pharmaceuticals. 2023;16(10):1456 [Crossref]
13- Varan G, Akkın S, Demirtürk N, Benito J, Bilensoy E. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver. Journal of Drug Targeting. 2021;29(4):439 [Crossref]
14- Dali P, Shende P. Inclusion complex of cyclodextrin with ergotamine and evaluation of cyclodextrin-based nanosponges. J Incl Phenom Macrocycl Chem. 2022;102(7-8):669 [Crossref]
15- Mandani S, Rezaei B, Ensafi A, Sabzalian M. Development of a new simple spectroscopic determination coupled acid-motivated delivery system based on fluorescence turn-off MSNs@MPA-ZnS QDs for infection. Microporous and Mesoporous Materials. 2021;317:110971 [Crossref]
16- Li T, Guo R, Zong Q, Ling G. Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin. Carbohydrate Polymers. 2022;276:118644 [Crossref]
17- Haegebaert R, Kempers M, Ceelen W, Lentacker I, Remaut K. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer. European Journal of Pharmaceutics and Biopharmaceutics. 2022;172:16 [Crossref]
18- Mukherjee S, Mazumder P, Joshi M, Joshi C, Dalvi S, Kumar M. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review. Environmental Research. 2020;191:110119 [Crossref]
19- Khajir S, Karimzadeh Z, Khoubnasabjafari M, Jouyban-Gharamaleki V, Rahimpour E, Jouyban A. A Rayleigh light scattering technique based on β- cyclodextrin modified gold nanoparticles for phenytoin determination in exhaled breath condensate. Journal of Pharmaceutical and Biomedical Analysis. 2023;223:115141 [Crossref]
20- Rivero-Barbarroja G, Benito J, Ortiz Mellet C, García Fernández J. Cyclodextrin-Based Functional Glyconanomaterials. Nanomaterials. 2020;10(12):2517 [Crossref]
21- Salari A, Roshanaei K, Rasoulian B, Fard J. Carvacrol loaded beta cyclodextrin-alginate-chitosan based nanoflowers attenuates renal toxicity induced by malathion and parathion: A comparative toxicity. Pesticide Biochemistry and Physiology. 2021;172:104747 [Crossref]
22- Tomou E, Papakyriakopoulou P, Saitani E, Valsami G, Pippa N, Skaltsa H. Recent Advances in Nanoformulations for Quercetin Delivery. Pharmaceutics. 2023;15(6):1656 [Crossref]
23- Arya P, Raghav N. In-vitro studies of Curcumin-β-cyclodextrin inclusion complex as sustained release system. Journal of Molecular Structure. 2021;1228:129774 [Crossref]
24- Elmoghayer M, Saleh N, Abu Hashim I. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Drug Deliv and Transl Res. 2024;14(4):895 [Crossref]
25- Muruganantham S, Krishnaswami V, Alagarsamy S, Kandasamy R. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis. CDT. 2021;22(4):399 [Crossref]
26- Lu Q. Bioresponsive and multifunctional cyclodextrin-based non-viral nanocomplexes in cancer therapy: Building foundations for gene and drug delivery, immunotherapy and bioimaging. Environmental Research. 2023;234:116507 [Crossref]
27- Real D, Bolaños K, Priotti J, Yutronic N, Kogan M, Sierpe R, Donoso-González O. Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability. Pharmaceutics. 2021;13(12):2131 [Crossref]
28- Pawar C, Rajendra Prasad N, Yadav P, Muthu Vijayan Enoch I, Manikantan V, Dey B, Baruah P. Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance. International Journal of Pharmaceutics. 2023;635:122763 [Crossref]
29- Choi S, Talmon G, Britigan B, Narayanasamy P. Nanoparticulate β-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against Mycobacteroides abscessus and Mycobacterium avium. ACS Infect Dis. 2021;7(8):2299 [Crossref]
30- Singh D, Sharma Y, Dheer D, Shankar R. Stimuli responsiveness of recent biomacromolecular systems (concept to market): A review. International Journal of Biological Macromolecules. 2024;261:129901 [Crossref]
31- Chenglin Z, Jihao S, Hongxia Z, Yang L, Xu Z. Suger-coated pillararenes for drug delivery applications. E3S Web Conf. 2020;185:03048 [Crossref]
32- Pestovsky Y, Srichana T. Formation of Aggregate-Free Gold Nanoparticles in the Cyclodextrin-Tetrachloroaurate System Follows Finke–Watzky Kinetics. Nanomaterials. 2022;12(4):583 [Crossref]
33- Raguzin E, Yudin M, Glushenko D, Vengerovich N, Raguzina O, Pechurina T, Shefer T, Ivanov I. Analysis and Evaluation of Modern Approaches to Development of Medical Drugs Using Micro- and Nanotechnologies. IP Pavlov Russian Medical Biological Herald. 2022;30(3):397 [Crossref]
34- Holzinger M, Buzzetti P, Cosnier S. Polymers and nano-objects, a rational combination for developing health monitoring biosensors. Sensors and Actuators B: Chemical. 2021;348:130700 [Crossref]
35- Guleria A, Aishwarya J, Kunwar A, Neogy S, Debnath A, Rath M, Adhikari S, Tyagi A. Solvated electron-induced synthesis of cyclodextrin-coated Pd nanoparticles: mechanistic, catalytic, and anticancer studies. Dalton Trans. 2023;52(4):1036 [Crossref]
36- Rajamohan R, Ashokkumar S, Lee Y. Environmental free synthesis of biologically active Cu2O nanoparticles for the cytotoxicity. Journal of Molecular Structure. 2023;1271:134081 [Crossref]
37- Singh N, Mudassir M, Ansari S, Chosdol K, Sinha S, Chattopadhyay P. Poly(lactic-co-glycolic) acid nanoparticles localize in vesicles after diffusing into cells and are retained by intracellular traffic modulators. Nanomedicine. 2023; [Crossref]
38- Bonfield T, Zuckerman S, Sutton M, Korley J, von Recum H. Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infections. J Biomedical Materials Res. 2024; [Crossref]
39- Carvalho R, Rosa I, Gomes D, Goliatt P, Goliatt L. Gaussian processes regression for cyclodextrin host-guest binding prediction. J Incl Phenom Macrocycl Chem. 2021;101(1-2):149 [Crossref]
40- Tarannum N, Kumar D, Kumar N. β‐Cyclodextrin‐Based Nanocomposite Derivatives: State of the Art in Synthesis, Characterization and Application in Molecular Recognition. ChemistrySelect. 2022;7(22) [Crossref]
41- Pant A, Sharma G, Saini S, Kaur G, Jain A, Thakur A, Singh B. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies. Drug Deliv and Transl Res. 2024;14(3):730 [Crossref]
42- Pilch J, Kowalik P, Kowalczyk A, Bujak P, Kasprzak A, Paluszkiewicz E, Augustin E, Nowicka A. Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells. IJMS. 2022;23(3):1261 [Crossref]
43- Jampilek J, Kralova K. Advances in Nanostructures for Antimicrobial Therapy. Materials. 2022;15(7):2388 [Crossref]
44- Kumar V, Sharma N, Janghu P, Pasrija R, Umesh M, Chakraborty P, Sarojini S, Thomas J. Synthesis and characterization of chitosan nanofibers for wound healing and drug delivery application. Journal of Drug Delivery Science and Technology. 2023;87:104858 [Crossref]
45- Lima Cavalcanti I, Xavier Junior F, Santos Magalhães N, Lira Nogueira M. Isothermal titration calorimetry (ITC) as a promising tool in pharmaceutical nanotechnology. International Journal of Pharmaceutics. 2023;641:123063 [Crossref]
46- Ricci F, Racaniello G, Lopedota A, Laquintana V, Arduino I, Lopalco A, Cutrignelli A, Franco M, Sigurdsson H, Denora N. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. International Journal of Pharmaceutics. 2022;622:121905 [Crossref]
47- Zhang K, Ren X, Chen J, Wang C, He S, Chen X, Xiong T, Su J, Wang S, Zhu W, Zhang J, Wu L. Particle Design and Inhalation Delivery of Iodine for Upper Respiratory Tract Infection Therapy. AAPS PharmSciTech. 2022;23(6) [Crossref]
48- Jackson B, Cluck D, Henao-Martínez A, Chastain D. Kimyrsa and Orbactiv – A Tale of Two Formulations. DDDT. 2023;Volume 17:737 [Crossref]
49- Guleria A, Gandhi V, Kunwar A, Debnath A, Adhikari S. Highly stable spherical shaped and blue photoluminescent cyclodextrin-coated tellurium nanocomposites prepared by in situ generated solvated electrons: a rapid green method and mechanistic and anticancer studies. Dalton Trans. 2022;51(16):6366 [Crossref]
50- Abdellatif A, Ahmed F, Mohammed A, Alsharidah M, Al-Subaiyel A, Samman W, Alhaddad A, Al-Mijalli S, Amin M, Barakat H, Osman S. Recent Advances in the Pharmaceutical and Biomedical Applications of Cyclodextrin-Capped Gold Nanoparticles. IJN. 2023;Volume 18:3247 [Crossref]
51- Majumder S, Eckersall P, George S. Bovine Mastitis: Examining Factors Contributing to Treatment Failure and Prospects of Nano-enabled Antibacterial Combination Therapy. ACS Agric Sci Technol. 2023;3(7):562 [Crossref]
52- Meylina L, Muchtaridi M, Joni I, Mohammed A, Wathoni N. Nanoformulations of α-Mangostin for Cancer Drug Delivery System. Pharmaceutics. 2021;13(12):1993 [Crossref]
53- Alboabdullah A, Goodarzi M, Homayouni Tabrizi M. The Lawson-loaded β-cyclodextrin nanocarriers (LB-NCs) a novel targeted cancer cell in stomach and breast cancer as a drug delivery system. Naunyn-Schmiedeberg's Arch Pharmacol. 2024; [Crossref]
54- Elbagory A, Marima R, Dlamini Z. Role and Merits of Green Based Nanocarriers in Cancer Treatment. Cancers. 2021;13(22):5686 [Crossref]
55- Heidari Nia M, Ashkar S, Munguia-Lopez J, Kinsella J, van de Ven T. Hairy Nanocellulose-Based Supramolecular Architectures for Sustained Drug Release. Biomacromolecules. 2023;24(5):2100 [Crossref]
56- Christoforides E, Andreou A, Papaioannou A, Bethanis K. Structural Studies of Piperine Inclusion Complexes in Native and Derivative β-Cyclodextrins. Biomolecules. 2022;12(12):1762 [Crossref]
57- Gayathri K, Bhaskaran M, Selvam C, Thilagavathi R. Nano formulation approaches for curcumin delivery- a review. Journal of Drug Delivery Science and Technology. 2023;82:104326 [Crossref]
58- Li X, Liu J, Qiu N. Cyclodextrin-Based Polymeric Drug Delivery Systems for Cancer Therapy. Polymers. 2023;15(6):1400 [Crossref]
59- Yousuf S, Alexander A, Sumohan Pillai A, Enoch I. Interaction of Atorvastatin-loaded magnetic iron oxide nanoparticles with DNA. Inorganic and Nano-Metal Chemistry. 2023;:1 [Crossref]
60- Gandhi S, Shende P. Cyclodextrins-modified metallic nanoparticles for effective cancer therapy. Journal of Controlled Release. 2021;339:41 [Crossref]
61- Hidayat M, Fitrayani N, Alik Samma A, Anggriani A, Permana A. Validation of spectrophotometric and colorimetric methods for determination of efavirenz in various biological matrices: Application to the development of dissolvable microneedle-based efavirenz complex inclusion for vaginal delivery. Microchemical Journal. 2024;200:110361 [Crossref]
62- Bohloli A, Asli M, Moniri E, Gh A. Modification of WS2 nanosheets with beta-cyclodextrone and N-isopropylacrylamide polymers for tamoxifen adsorption and investigation of in vitro drug release. Res Chem Intermed. 2021;47(5):1955 [Crossref]
63- Khan M, Khan S, Kazi M, Alshehri S, Shahid M, Khan S, Hussain Z, Sohail M, Shafique M, Hamid H, Kamran M, Elhissi A, Wasim M, Thu H. Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation. Pharmaceutics. 2021;13(10):1632 [Crossref]
64- Sybachin A, Pigareva V. Ensembles of carboxymethyl cyclodextrins on cationic liposomes as highly efficient nanocontainers for the delivery of hydrophobic compounds. Biochimica et Biophysica Acta (BBA) - General Subjects. 2023;1867(6):130363 [Crossref]
65- Maddiboyina B, Roy H, Ramaiah M, Sarvesh C, Kosuru S, Nakkala R, Nayak B. Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs. Bull Natl Res Cent. 2023;47(1) [Crossref]
66- Reichardt S, Amouret A, Muzzi C, Vettorazzi S, Tuckermann J, Lühder F, Reichardt H. The Role of Glucocorticoids in Inflammatory Diseases. Cells. 2021;10(11):2921 [Crossref]
67- Quintana-Contardo S, Donoso-González O, Lang E, Guerrero A, Noyong M, Simon U, Kogan M, Yutronic N, Sierpe R. Optimizing Dacarbazine Therapy: Design of a Laser-Triggered Delivery System Based on β-Cyclodextrin and Plasmonic Gold Nanoparticles. Pharmaceutics. 2023;15(2):458 [Crossref]
68- Mazyed E, Badria F, ElNaggar M, El-Masry S, Helmy S. Development of Cyclodextrin-Functionalized Transethoniosomes of 6-Gingerol: Statistical Optimization, In Vitro Characterization and Assessment of Cytotoxic and Anti-Inflammatory Effects. Pharmaceutics. 2022;14(6):1170 [Crossref]